Viewing Study NCT00004467


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2025-12-25 @ 10:58 PM
Study NCT ID: NCT00004467
Status: COMPLETED
Last Update Posted: 2017-10-13
First Post: 1999-10-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2017-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: True
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: OBJECTIVES:

I. Determine the safety and efficacy of a short course (72 hours) of intravenous acetylcysteine in patients with acute liver failure for whom no antidote or specific treatment is available.
Detailed Description: PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive intravenous acetylcysteine or placebo for 72 hours. Treatment must begin within 12 hours of hospitalization. Patients who advance to grade III or IV encephalopathy are eligible for liver transplantation.

Patients are followed at 3 weeks.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

NCT ID Aliases

NCT ID Alias NCT ID View
None NCT00004467 View
None NCT00004467 View

Secondary ID Infos

Secondary ID Type Domain Link View
R03DK052827 NIH None https://reporter.nih.gov/quic… View
UTSMC-IRB-0697-27200 OTHER University of Texas Southwest Medical Center View
R01DK058369 NIH None https://reporter.nih.gov/quic… View
U01DK058369 NIH None https://reporter.nih.gov/quic… View